The DOI matches its Crossref record; 42 of the 43 references it cites were found in a registry or an index.
Efficacy and Safety of Ephedra and Ephedrine for Weight Loss and Athletic Performance: A Meta-analysis
Open accessAbstract
Context: Ephedra and ephedrine sometimes are used for weight loss or enhanced athletic performance, but the efficacy and safety of these compounds are uncertain. Objective: To assess the efficacy and safety of ephedra and ephedrine used for weight loss and enhanced athletic performance. Data Sources: We searched 9 databases using the terms ephedra , ephedrine , adverse effect , side effect , efficacy , effective , and toxic . We included unpublished trials and non–English-language documents. Adverse events reported to the US Food and Drug Administration MedWatch program were assessed. Study Selection: Eligible studies were controlled trials of ephedra or ephedrine used for weight loss or athletic performance and case reports of adverse events associated with such use. Eligible studies for weight loss were human studies with at least 8 weeks of follow-up; and for athletic performance, those having no minimum follow-up. Eligible case reports documented that ephedra or ephedrine was consumed within 24 hours prior to an adverse event or that ephedrine or an associated product was found in blood or urine, and that other potential causes had been excluded. Of the 530 articles screened, 52 controlled trials and 65 case reports were included in the adverse events analysis. Of more than 18 000 other case reports screened, 284 underwent detailed review. Data Extraction: Two reviewers independently identified trials of efficacy and safety of ephedra and ephedrine on weight loss or athletic performance; disagreements were resolved by consensus. Case reports were reviewed with explicit and implicit methods. Data Synthesis: No weight loss trials assessed duration of treatment greater than 6 months. Pooled results for trials comparing placebo with ephedrine (n = 5), ephedrine and caffeine (n = 12), ephedra (n = 1), and ephedra and herbs containing caffeine (n = 4) yielded estimates of weight loss (more than placebo) of 0.6 (95% confidence interval, 0.2-1.0), 1.0 (0.7-1.3), 0.8 (0.4-1.2), and 1.0 (0.6-1.3) kg/mo, respectively. Sensitivity analyses did not substantially alter the latter 3 results. No trials of ephedra and athletic performance were found; 7 trials of ephedrine were too heterogeneous to synthesize. Safety data from 50 trials yielded estimates of 2.2- to 3.6-fold increases in odds of psychiatric, autonomic, or gastrointestinal symptoms, and heart palpitations. Data are insufficient to draw conclusions about adverse events occurring at a rate less than 1.0 per thousand. The majority of case reports are insufficiently documented to allow meaningful assessment. Conclusions: Ephedrine and ephedra promote modest short-term weight loss (≈0.9 kg/mo more than placebo) in clinical trials. There are no data regarding long-term weight loss, and evidence to support use of ephedra for athletic performance is insufficient. Use of ephedra or ephedrine and caffeine is associated with increased risk of psychiatric, autonomic, or gastrointestinal symptoms, and heart palpitations.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Unfortunately, ephedrine is associated with increased risk of psychiatric, autonomic, gastrointestinal, and cardiovascular symptoms 134, which likely will preclude the use of ephedrine itself for the treatment of obesity.”
From Cellular bioenergetics as a target for obesity therapy (2010) · cites this paper as [134]
In the citing paper
“A meta-analysis of several dozen trials showed that ephedrine promotes modest short-term weight loss, but there are no data on longer-term efficacy 134.”
From Cellular bioenergetics as a target for obesity therapy (2010) · cites this paper as [134]
In the citing paper
“Unfortunately, ephedrine is associated with increased risk of psychiatric, autonomic, gastrointestinal, and cardiovascular symptoms 134, which likely will preclude the use of ephedrine itself for the treatment of obesity.”
From Cellular bioenergetics as a target for obesity therapy (2010) · cites this paper as [134]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Bias in meta-analysis detected by a simple, graphical test
Egger, M., Smith, G. D., Schneider, M., & Minder, C. (1997) · BMJ · doi:10.1136/bmj.315.7109.629 · Cited by 56,722
Meta-analysis in clinical trials
DerSimonian, R., & Laird, N. (1986) · Controlled Clinical Trials · doi:10.1016/0197-2456(86)90046-2 · Cited by 39,552
Assessing the quality of reports of randomized clinical trials: Is blinding necessary?
Jadad, A. R., Moore, R. A., Carroll, D., Jenkinson, C., Reynolds, D. J. M., Gavaghan, D. J., & McQuay, H. J. (1996) · Controlled Clinical Trials · doi:10.1016/0197-2456(95)00134-4 · Cited by 17,582
Operating characteristics of a rank correlation test for publication bias
Begg, C. B., & Mazumdar, M. (1994) · Biometrics · doi:10.2307/2533446 · Cited by 16,955
Moher, D., Pham, B., Jones, A., Cook, D. J., Jadad, A. R., Moher, M., Tugwell, P., & Klassen, T. P. (1998) · The Lancet · doi:10.1016/s0140-6736(98)01085-x · Cited by 3,560
Higgins (2002) · doi:10.1002/(issn)1097-0258 · Cited by 1,248
Haller, C. A., & Benowitz, N. L. (2000) · New England Journal of Medicine · doi:10.1056/nejm200012213432502 · Cited by 956
A random‐effects regression model for meta‐analysis
Berkey, C. S., Hoaglin, D. C., Mosteller, F. C., & Colditz, G. A. (1995) · Statistics in Medicine · doi:10.1002/sim.4780140406 · Cited by 896
Orlistat, a lipase inhibitor, for weight maintenance after conventional dieting: a 1-y study.
Hill, J. O., Hauptman, J., Anderson, J. W., Fujioka, K., O'Neil, P. M., Smith, D. K., Zavoral, J. H., & Aronne, L. J. (1999) · The American Journal of Clinical Nutrition · doi:10.1093/ajcn/69.6.1108 · Cited by 287 · cited 8×
“Molnar et al,27 2000 4 Ephedrine (30-60) and caffeine (100 for 1 wk) 20 wk 16 16 0.”
InfluentialLong-term Weight Loss With Sibutramine
Wirth, A. G., & Krause, J. (2001) · JAMA · doi:10.1001/jama.286.11.1331 · Cited by 267
Research works printed but not linked: 13
- Abrahamson, 2001, Wheeler used supplement., Los Angeles Times
- Carey, 2001, Risks of ephedra usage in spotlight., Los Angeles Times
- Marsa, 2002, A tug of war in a larger battle: ephedra is now under intense scrutiny., Los Angeles Times
- Moheb, 1998, Effect of ephedrine, caffeine, and aspirin, in combinations of weight loss in obese women [abstract]., Int J Obes Relat Metab Disord, 22, S264
- Colker, 2001, A pilot study evaluating the effects of an ephedrine and forskolin-based product on body weight and body composition in overweight, healthy women [abstract]., J Am Coll Nutr, 20, 98
- Jensen, 1980, Elsinore tablets and ephedrine as slimming agents [in Danish]., Ugeskr Laeger, 142, 1499
- Kettle, 1998, Ephedrine/caffeine enhances abdominal fat loss in females., Int J Obes Relat Metab Disord, 22, S264
- Lumholtz, 1980, Ephedrine in the treatment of obesity [in Danish]., Ugeskr Laeger, 142, 1487
- Quaade, 1992, The effect of an ephedrine/caffeine combination as a supplement to a weight-reducing diet [in Danish]., Ugeskr Laeger, 154, 1258
- Roed, 1980, Elsinore banting tablets [in Danish]., Ugeskr Laeger, 142, 1491
- Breum, 1994, Comparison of an ephedrine/caffeine combination and dexfenfluramine in the treatment of obesity., Int J Obes Relat Metab Disord, 18, 99
- Not Available, 2001, >Stata [computer program].
- Not Available, 2000, StatXact 4 [computer program].
Cited by
Sorted by citations
Items 401–500 of 511
Ephedra, ephedrine, and pseudoephedrine
(2015) · Elsevier eBooks · doi:10.1016/b978-0-444-53717-1.00690-9 · Cited by 1
Principles of Energy Homeostasis
Ahima, R. S. (2023) · Springer eBooks · doi:10.1007/978-3-319-12125-3_48-2 · Cited by 1
Stankus, T. (2004) · Reference & User Services Quarterly · Cited by 1
Safety Assessment Versus Efficacy Assessment
Foulkes, M. A. (2007) · Birkhäuser Boston eBooks · doi:10.1007/978-0-8176-4542-7_21 · Cited by 1
The World Anti-Doping Code: Truths and Wrongs
Gepdíremen, A. (2018) · Bezmialem Science · doi:10.14235/bs.2018.2112 · Cited by 1
Valencia, I., López-Sandoval, H. C., Ávila-Torres, Y., Castro, M., & Barba-Behrens, N. (2019) · Journal of Molecular Structure · doi:10.1016/j.molstruc.2019.127200 · Cited by 1
Brust, J. C. M. (2015) · Elsevier eBooks · doi:10.1016/b978-0-323-29544-4.00039-6 · Cited by 1
Kim, K., Kim, S., Kim, H., Shin, S.-U., Song, J., & Chung, W. (2020) · Medicine · doi:10.1097/md.0000000000020817 · Cited by 1
US Poisons Control Centers and reports of adverse events associated with dietary supplements
(2003) · Focus on Alternative and Complementary Therapies · doi:10.1211/fact.2003.00311 · Cited by 1
Body image and weight management : young people, internet advertisements and pharmacists
Luevorasirikul, K. (2007) · Nottingham ePrints (University of Nottingham) · Cited by 1
Ephedra: plezier, presteren en afslanken
Barendregt, C., & Boon, B. J. F. (2006) · Verslaving · doi:10.1007/bf03075338 · Cited by 1
More Evidence Supporting the Ban of Ephedra Dietary Supplements
Chavez, M. L. (2004) · Annals of Pharmacotherapy · doi:10.1345/aph.1e033 · Cited by 1
Reciprocal regulation of gene expression by Ephedra herba in mouse brain
Kim, B., Cao, L. H., Park, H., & Jeong, S. (2009) · Phytotherapy Research · doi:10.1002/ptr.2976 · Cited by 1
Invited Commentary—The Safety of Dietary Supplements
Shekelle, P. (2010) · Archives of Internal Medicine · doi:10.1001/archinternmed.2010.291 · Cited by 1
Self-citationLaguë, J. (2008) · Cited by 1
Amphetamine and Other Psychostimulants
Brust, J. C. M. (2004) · Elsevier eBooks · doi:10.1016/b978-0-7506-7313-6.50008-8 · Cited by 1
Tang, L. (2018) · Deep Blue (University of Michigan) · Cited by 1
Brust, J. C. M. (2011) · Elsevier eBooks · doi:10.1016/b978-1-4160-5478-8.10042-9 · Cited by 1
Ergogenic Aids and the Female Athlete
Robert-McComb, J. J., & Jordan, S. L. (2007) · Humana Press eBooks · doi:10.1007/978-1-59745-534-3_27 · Cited by 1
Chinese herbal medicines for weight loss
Teng, L., & Barnes, J. (2007) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd006381 · Cited by 1
Zhang (2019) · Research Publications (Maastricht University) · doi:10.26481/dis.20190701mz
Thoenes, M., Zhang, Z., Rathgeber, D., Bramlage, P., & Kirch, W. (2009) · Springer eBooks · doi:10.1007/978-3-540-73042-2_44
A Status of Drugs on the Horizon for Obesity and the Metabolic Syndrome—a Comprehensive Review 2005
Greenway, F. L., & Bray, G. A. (2007) · Springer eBooks · doi:10.1007/978-0-387-32164-6_16
Cullum‐Dugan, D., & Saper, R. B. (2009) · Elsevier eBooks · doi:10.1016/b978-84-458-1911-1.50039-7
Cardiovascular Effects of Ephedra
Ness, J. (2004) · JAMA · doi:10.1001/jama.291.13.1560-b
Barceloux, D. G. (2008) · doi:10.1002/9780470330319.ch79
Mohr, C. R. (2009) · Humana Press eBooks · doi:10.1007/978-1-59745-302-8_21
Doping in Children and Adolescents
Rawson, E. S., & Persky, A. M. (2007) · Wiley eBooks · doi:10.1002/9780470696255.ch21
Does the future of phytomedicine lie in using plants to isolate bioactive components?
Canter, P. H., & Mills, S. Y. (2007) · Focus on Alternative and Complementary Therapies · doi:10.1211/fact.12.2.0005
Ergogenic Aids and the Female Athlete
Jordan, S. L., & Naclerio, F. (2013) · Springer eBooks · doi:10.1007/978-1-4614-8884-2_30
Regulation of Dietary Supplements—Reply
DeAngelis, C. D., & Fontanarosa, P. (2004) · JAMA · doi:10.1001/jama.291.5.560-b
Rawson, E. S., Brightbill, C. E., & Stec, M. J. (2013) · Wiley eBooks · doi:10.1002/9781118692318.ch45
Systematic and critical evaluation of benefits and possible risks of nutritional ergogenic aids.
Turpin, A., Talbott, S., Feliciano, J., & Bucci, L. R. (2004) · doi:10.1201/9780203507704-25
Chinese herbal medicines for weight loss
Teng, L., Shaw, D., & Barnes, J. (2014) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd006381.pub2
Drugs that affect autonomic functions or the extrapyramidal system
Schächter, M. (2010) · Side effects of drugs annual · doi:10.1016/s0378-6080(10)32013-7
Regulation of Ephedra in the United States
Motoo, Y., & Uchide, K. (2003) · The American Journal of Chinese Medicine · doi:10.1142/s0192415x03001569
Cardiac Effects of Ergogenic Aides and Supplements
Benjamin, H. J., & Congeni, J. A. (2010) · Springer eBooks · doi:10.1007/978-0-387-92775-6_20
Drugs that affect autonomic functions or the extrapyramidal system
Aronson, J. K. (2012) · Side effects of drugs annual · doi:10.1016/b978-0-444-59499-0.00013-1
Occurrence and Causes of Obesity in Albanian Young People
Pojani, E. (2014) · Mediterranean Journal of Social Sciences · doi:10.5901/mjss.2014.v5n19p33
A deficiency of Yang by overuse of Ephedra in traditional medicinal aspects
Jung, J. H., & Choi, I. S. (2013) · TANG [HUMANITAS MEDICINE] · doi:10.5667/tang.2012.0046
WEIGHT LOSS SUPPLEMENT USE BY GYM CLIENTELE
White, B. D. (2007)
Kim, N. J., Kim, C. H., Cho, J. H., Ko, S. M., & Min, B. (2011) · Intestinal Research · doi:10.5217/ir.2011.9.3.230
Performance-enhancing drugs, supplements and the athlete’s heart
Pipe, A. (2017) · SA Heart · doi:10.24170/8-3-1895
XILANAS DE SABUGO DE MILHO COMO AGENTE ANTIOXIDANTE, CITOTÓXICO, ANTICOAGULANTE E IMUNOMODULADOR
Silveira, R. F. D. M. (2014) · Americanae (AECID Library)
Anesthesia and Herbal Supplements
Danloff, T. A. (2012) · ASA Refresher Courses in Anesthesiology · doi:10.1097/asa.0b013e31825f1b6a
Castillo‐Henkel, C., Guzmán-Lozano, N. L., López‐Canales, J. S., Guevara‐Balcázar, G., Asbún‐Bojalil, J., Rodríguez-Choreño, D., Morín-Zaragoza, R., Villanueva, C., & Mendoza-Zepeda, R. (2010) · Revista del Hospital Juárez de México
Risks of Ephedra and Ephedrine
Stapleton, F. B. (2003) · Journal watch · doi:10.1056/pa200304280000001
Cohen, S. N. (2004) · Journal of the Neurological Sciences · doi:10.1016/j.jns.2004.03.030
Lessons from the Use of Ephedra Products as a Dietary Supplement
Soni, M. G., Shelke, K., Amin, R., & Talati, A. R. (2012)
COMPLEMENTARY AND ALTERNATIVE MEDICINE, NUTRACEUTICALS, AND DIETARY SUPPLEMENTS
HALLER, C. A. (2009) · Elsevier eBooks · doi:10.1016/b978-1-4160-3291-5.50094-9
Amphétamine et autres psychostimulants
Brust, J. C. M. (2007) · Elsevier eBooks · doi:10.1016/b978-2-84299-712-0.50004-8
Cardiovascular Effects of Obesity
Albrecht, M. A. A. A. R. F., II (2013) · CRC Press eBooks · doi:10.3109/9781420095319-3
Calkins, J., Glatter, K. A., & Ayirookuzhi, S. J. (2007) · CRC Press eBooks · doi:10.1201/9781420054569.ch10
Plantes à l'officine : soyons phytovigilants !
Aigueperse, L. (2014) · HAL
Systematic reviews as a guide to practice: illumination or obfuscation?
Hardy, M. L. (2006) · Focus on Alternative and Complementary Therapies · doi:10.1211/fact.11.2.0002
Self-citationChapter 24: Sports Nutrition and Performance-Enhancing Nutrients and Supplements
Newnham, M. (2015) · The American Pharmacists Association eBooks · doi:10.21019/9781582122250.ch24
Plant-Derived Drugs Affecting GPRCs
Böttger, A., Vothknecht, U. C., Bolle, C., & Wolf, A. (2018) · Learning materials in biosciences · doi:10.1007/978-3-319-99546-5_7
Dietary Supplements: Reports Reviewed by Tia Powell and Barbara A. Noah
Powell, T., & Noah, B. A. (2005) · The Journal of Law Medicine & Ethics · doi:10.1111/j.1748-720x.2005.tb00552.x
Chapter 25: Sports Nutrition and Performance-Enhancing Nutrients and Supplements
Newnham, M. (2017) · The American Pharmacists Association eBooks · doi:10.21019/9781582122656.ch25
(2010) · CRC Press eBooks · doi:10.3109/9781420092264-16
Levy, J. L., Cabrera, J., Thomas, S. F., & Brennan, F. H. (2008) · Elsevier eBooks · doi:10.1016/b978-141603197-0.10048-5
Bob-Chile, A. A., & Amadi, P. U. (2020) · Brazilian Journal of Biological Sciences · doi:10.21472/bjbs(2020)071505
Herbal slimming products and natural sexual enhancers
Onisei, T., Micu, A. M., & Rascol, M. (2021) · Elsevier eBooks · doi:10.1016/b978-0-12-822716-9.00010-x
Esk, R., & arani (2021) · Journal of Clinical Toxicology
Drugs that affect autonomic functions or the extrapyramidal system
Aronson, J. K. (2009) · Side effects of drugs annual · doi:10.1016/s0378-6080(09)03113-4
Brust, J. C. M. (2021) · Elsevier eBooks · doi:10.1016/b978-0-323-69424-7.00039-9
Knowles, J. B. (2004) · Wiley eBooks · doi:10.1002/9780470987025.ch22
Current awareness: Pharmacoepidemiology and drug safety
(2003) · Pharmacoepidemiology and Drug Safety · doi:10.1002/pds.792
Karch, S. B. (2006) · CRC Press eBooks · doi:10.1201/9781420003468.ch13
Caffeine, Creatine, and Food—Drug Synergy
Moisey, L. L., & Graham, T. E. (2005) · CRC Press eBooks · doi:10.1201/9781420038255.sec6
Rangan, C. (2012) · doi:10.1002/9781118105955.ch13
(2011) · CRC Press eBooks · doi:10.1201/b10790-15
Piante medicinali e disturbi metabolici
(2006) · Springer eBooks · doi:10.1007/88-470-0505-1_23
Greenway, F. L., & Gupta, A. (2007) · CRC Press eBooks · doi:10.1201/9781420005479.pt5
Cullum‐Dugan, D., & Saper, R. B. (2007) · Elsevier eBooks · doi:10.1016/b978-1-4160-2954-0.50043-0
Systematic and Critical Evaluation of Benefits and Possible Risks of Nutritional Ergogenic Aids
Bucci, L. R., Turpin, A., Talbott, S., & Feliciano, J. (2004) · CRC Press eBooks · doi:10.1201/9780203507704.pt5
Lessons from the Use of Ephedra Products as Dietary Supplements
Shelke, K., Amin, R., & Soni, M. G. (2007) · CRC Press eBooks · doi:10.1201/9781420005479.ch38
13 Drugs that affect autonomic functions or the extrapyramidal system
Schächter, M. (2007) · Side effects of drugs annual · doi:10.1016/s0378-6080(06)29013-5
Sun, J., & Giraud, D. (2009) · CRC Press eBooks · doi:10.1201/9781420066029.ch13
Complementary and Alternative Medicine
Yussman, S. M., Sahler, O. J. Z., & Rosen, M. A. (2011) · Springer eBooks · doi:10.1007/978-1-4419-1695-2_103
Sudden Cardiac Deaths in Athletes, Including Commotio Cordis
Link, M. S., & Estes, N. A. M. (2013) · Elsevier eBooks · doi:10.1016/b978-1-4557-2856-5.00108-4
ADVERSE CARDIOVASCULAR EFFECTS OF NON-CARDIOVASCULAR DRUGS
(2009) · Elsevier eBooks · doi:10.1016/b978-0-444-53268-8.50009-0
Cardiovascular Effects of Obesity
Albrecht, M. A., & Albrecht, R. F. (2009) · CRC Press eBooks · doi:10.3109/9781420095319-2
Drugs that affect autonomic functions or the extrapyramidal system/
Schächter, M. (2005) · Side effects of drugs annual · doi:10.1016/s0378-6080(05)80435-0
(2008) · Obesity Management · doi:10.1089/obe.2008.0209
Behiry, S., Matarese, L. E., & Kandil, H. M. (2015) · CRC Press eBooks · doi:10.1201/b18833-14
Dey, L., & Yuan, C. (2011) · CRC Press eBooks · doi:10.3109/9781841848433-19
CrossRef Listing of Deleted DOIs
(2007) · CrossRef Listing of Deleted DOIs · doi:10.1007/s11932-003-0009-2
Compounds found in Herbal products
(2009) · Elsevier eBooks · doi:10.1016/b978-0-444-53269-5.50006-6
Chapter 25: Sports Nutrition and Performance-Enhancing Nutrients and Supplements
Newnham, M. (2020) · The American Pharmacists Association eBooks · doi:10.21019/9781582123172.ch25
Behiry, S., Matarese, L. E., & Kandil, H. M. (2017) · CRC Press eBooks · doi:10.1201/9781315100913-14
Novel drugs in pharmacotherapy of obesity
Hartinger, J. M. (2021) · Praktické lékárenství · doi:10.36290/lek.2021.015
Doping Terhadap Kardiovaskular
Divisi Kardiologi Intervensi, R. J. D. S., Laksono, S., Hosea, G. T., & Fakultas Kedokteran Universitas Pelita Harapan, T. (2022) · Jurnal Porkes · doi:10.29408/porkes.v5i1.5407
(2003) · Focus on Alternative and Complementary Therapies · doi:10.1211/fact.2003.00331
Tammy, N., Warrick, A. E., Paula, C., & Marcia, F. (2023) · Elsevier eBooks · doi:10.1016/b978-0-323-99992-2.00061-x
Metadata
- Authors
- Shekelle, P. G., Hardy, M. L., Morton, S. C., Maglione, M., Mojica, W. A., Suttorp, M. J., Rhodes, S. L., Jungvig, L., & Gagné, J.
- Affiliations
- RAND Corporation (US)
- Cedars-Sinai Medical Center (US)
- University of Southern California (US)
- Venue
- JAMA
- Publisher
- American Medical Association (AMA)
- Published
- 2003-03-26
- Volume
- 289
- Issue
- 12
- Pages
- 1537
- ISSN
- 0002-9955 (ISSN-L)
- 0098-7484
- OpenAlex
- W1999289755
- Cited by
- 511
- References
- 43
- Citations by year
- 2026: 6 · 2025: 9 · 2024: 10 · 2023: 11 · 2022: 15 · 2021: 15 · 2020: 9 · 2019: 15 · 2018: 16 · 2017: 16 · 2016: 19 · 2015: 21 · 2014: 20 · 2013: 17 · 2012: 23
- FWCI
- 5.63
- Type
- journal article
- Language
- en
- Open access
- bronze
- doi.org
- Locations
- JAMA (publishedVersion)
- PubMed (publishedVersion)
- VTechWorks (Virginia Tech) (submittedVersion)
- Funders
- U.S. Department of Veterans Affairs
- Health Services Research and Development
- U.S. Public Health Service (290-97-0001)
- Topics
- Health Sciences › Medicine › Pharmacology (medical) › Pharmacology and Obesity Treatment
- Social Sciences › Sociology and Political Science › Doping in Sports
- Life Sciences › Agricultural and Biological Sciences › Animal Science and Zoology › Pharmacological Effects and Assays
- Keywords
- Ephedra, ephedrine, weight loss, athletic performance, stimulants, caffeine, adverse events, drug safety, efficacy, herbal supplements, performance-enhancing drugs
- MeSH terms
- Caffeine, Ephedrine, Humans, Physical Endurance, Risk, Sports, Weight Loss, Randomized Controlled Trials as Topic, Controlled Clinical Trials as Topic, Anti-Obesity Agents, Dietary Supplements, Plant Preparations, Ephedra
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
